My key research area of interest is Phage biology,emphasizing phage-host interaction under invivo conditions to enhance and better understand the real challenges to successful phage therapy and thus motivated to contribute in making its way from bench to bed. At the moment, I am actively involved in optimising phage based intervention for E.coli O157:H7 which has been found to be associated with outbreaks and thus a potential threat.